Skip to content
The COVID Project
  1. Library
  2. State health licensing boards
  3. AGY-ST-HEALTH-BOARDS-017

Ex. AGY-ST-HEALTH-BOARDS-017 Order Primary source read

TSBP Guidance Statements re: COVID-19 (Issued May 15, 2020)

Guidance Statements re: COVID-19: dispensing in compliance with Emergency Board Rule 291.30 (hydroxychloroquine); diagnosis verification; off-label use

Texas State Board of Pharmacy · Texas State Board of Pharmacy; State level (Sector regulator)

The COVID Project

The record

Jurisdiction
Texas State Board of Pharmacy; State level · Texas
Level
Sector regulator
Authority
Tex. Occ. Code ch. 554; Emergency Board Rule 291.30
Issued
2020-05-15 May 15, 2020
Effective
2020-05-15
End
Tied to the life of Emergency Rule 291.30 (read as 2020-09-30)
In force
May 15, 2020 to Sept. 30, 2020
Quarters
2020 Q22020 Q3
Limitation types
Health care ordersSupply chain
Addressees
  • Texas pharmacists and pharmacies
  • prescribers
Functions reached
  • SC dispensing (diagnosis verification step compelled by rule)
  • CB prescribers and patients
Collection
State health licensing boards AGY-ST-HEALTH-BOARDS

Operative words

In addition, the Texas State Board of Pharmacy has issued the following guidance with regard to dispensing drugs in compliance with Emergency Board Rule 291.30: The rule does not prevent a physician from prescribing one of these drugs for an off-label use.... Pharmacists have a corresponding responsibility and use professional judgement when dispensing a prescription. Obtaining the diagnosis from the prescriber when dispensing a prescription by the pharmacist is not a violation of HIPAA.

Enforcement

Tex. Occ. Code §§ 565.001-.002; § 566.001

Notes

Confirms the emergency rule remained the operative constraint on dispensing in the second quarter of 2020